Last updated on March 2019

Study to Evaluate the Efficacy Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients


Brief description of study

This will be a double-blind, randomised, placebo-controlled parallel-arm phase II proof of concept in subjects with PD treated with a stable dose of levodopa who are experiencing both end-of-dose wearing off and Levodopa-Induced Dyskinesia (LID)

Clinical Study Identifier: NCT03162874

Contact Investigators or Research Sites near you

Start Over

Ernest Balaguer Martinez, MD

Hospital Universitari General de Catalunya
Sant Cugat del Vallès, Spain
  Connect »

Jaime Kulisevsky Bojarski, MD

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
5.53miles
  Connect »

Jorge Hernandez Vara, MD

Hospital Universitario Vall d'Hebron
Barcelona, Spain
5.53miles
  Connect »

Maria Jose Marti Domenech, MD

Hospital Cl nic de Barcelona
Barcelona, Spain
5.53miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.